In the current study, single-factor analysis during the 12-week course of interferon treatment unveiled a positive association between the elevation of patients’ ALT and AST levels and an augmented clinical cure rate for hepatitis B, a relationship supported by statistical significance (P < 0.05). This evidence concerns the gene GPT and hepatitis B virus infection.